Search Results - "Moriarty, Susan"

Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis: 52-week Results from a Phase III Study (SPIRIT-P1) by van der Heijde, Désirée, Gladman, Dafna D, Kishimoto, Mitsumasa, Okada, Masato, Rathmann, Suchitrita S, Moriarty, Susan R, Shuler, Catherine L, Carlier, Hilde, Benichou, Olivier, Mease, Philip J

“…To evaluate the efficacy and safety of ixekizumab (IXE), an interleukin 17A antagonist, in patients with psoriatic arthritis (PsA) after 52 weeks in a phase…”
Get full text

Safety of Ixekizumab in Patients With Psoriatic Arthritis: Results From a Pooled Analysis of Three Clinical Trials by Mease, Philip, Roussou, Euthalia, Burmester, Gerd‐Rüdiger, Goupille, Philippe, Gottlieb, Alice, Moriarty, Susan R., Benichou, Olivier, Adams, David H., Xu, Wen, Nash, Peter

“…Objective To evaluate ixekizumab safety in adults with psoriatic arthritis (PsA). Methods Safety data from 2 integrated data sets are presented: 1) 24‐week,…”
Get full text

A Randomized, Double-Blind Phase 2 Study Comparing the Efficacy and Safety of an Oral Fusidic Acid Loading-Dose Regimen to Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections by Craft, J. Carl, Moriarty, Susan R., Clark, Kay, Scott, Drusilla, Degenhardt, Thorsten P., Still, J. Gordon, Corey, G. Ralph, Das, Anita, Fernandes, Prabhavathi

“…Fusidic acid (CEM-102), an orally bioavailable fusidane antibiotic with a unique mode of action, is under development for treatment of acute gram-positive…”
Get full text

In vitro Characterization of Oritavancin Clearance from Human Blood by Low-Flux, High-Flux, and Continuous Renal Replacement Therapy Dialyzers by Kumar, Atul, Mann, Henry J., Keshtgarpour, Mani, Flynn, Michael A., Deng, Hong, Far, Adel Rafai, Parr, Thomas R., Moriarty, Susan R.

“…Background Oritavancin is an investigational lipoglycopeptide antibiotic under clinical development for the treatment of gram-positive bacterial infections…”
Get full text

Political commentary: fatal distraction by Moriarty, Susan

Get full text

None shall pass...without answering the call bell by Colancecco, Elise M, Moriarty, Susan, Litak, Lisa

“…Colancecco et al detail how they utilize the open access Studer Group's hourly rounding and no-pass zone models to help improve patient safety and nurse and…”
Get full text

A Randomized, Double-Blind Phase 2 Study Comparing the Efficacy and Safety of an Oral Fusidic Acid Loading-Dose Regimen to Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections: Fusidic Acid Enters the United States by CARL CRAFT, J, MORIARTY, Susan R, CLARK, Kay, SCOTT, Drusilla, DEGENHARDT, Thorsten P, GORDON STILL, J, RALPH COREY, G, DAS, Anita, FERNANDES, Prabhavathi

Get full text